InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (15 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
15
T+90 hit rate
18%
T+90 mean return
-21.4%
Across 22 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by McAnear Justin J., Chief Financial Officer. Officer active across 1 company, notably 10x Genomics, Inc.. Cumulatively, 40 filings have been published. Split: 1 buy · 15 sells. Total volume traded: €685k. History available since 3 May 2021. The latest transaction was filed on 22 August 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations40 total
2,961 shares@ US$22.52974.1% of flowClass A Common StockSEC:0001610717-24-000453:0
2,936 shares@ US$24.30364.5% of flowClass A Common StockSEC:0001610717-24-000259:0
53,312 shares0Class A Common StockSEC:0001610717-24-000184:0
1,865 shares@ US$46.34435.5% of flowClass A Common StockSEC:0001610717-24-000090:0
1,679 shares@ US$43.33674.6% of flowClass A Common StockSEC:0001610717-23-000365:0
1,678 shares@ US$45.78114.9% of flowClass A Common StockSEC:0001610717-23-000237:0
194 shares@ US$55.06950.7% of flowClass A Common StockSEC:0001610717-23-000064:0
25,991 shares0Class A Common StockSEC:0001140361-23-013504:0
1,245 shares@ US$47.75333.8% of flowClass A Common StockSEC:0001567619-23-003782:0
686 shares@ US$34.06511.6% of flowClass A Common StockSEC:0001567619-22-020869:0
20,297 shares0Class A Common StockSEC:0001567619-22-017565:0
987 shares@ US$35.19132.4% of flowClass A Common StockSEC:0001567619-22-016677:0
967 shares@ US$48.76410.0021% mcap4.5% of flowClass A Common StockSEC:0001567619-22-011713:0
158 shares@ US$40.48550.0003% mcap0.6% of flowClass A Common StockSEC:0001567619-22-011123:0
Ideal exit: 7 Feb 2023 (T+270)
21,357 shares0Class A Common StockSEC:0001567619-22-007440:0
288 shares@ US$78.59940.0010% mcap2.0% of flowClass A Common StockSEC:0001567619-22-005520:0
10,000 shares@ US$5.040.0021% mcap9.6% of flowClass A Common StockSEC:0001567619-22-000622
10,000 shares@ US$5.040.0021% mcap4.5% of flowClass A Common StockSEC:0001567619-22-000622:0
10,000 shares@ US$5.040.0021% mcap4.5% of flowClass A Common StockSEC:0001567619-21-021618:0
10,000 shares@ US$5.040.0021% mcap9.7% of flowClass A Common StockSEC:0001567619-21-021618
281 shares@ US$148.38110.0018% mcap3.7% of flowClass A Common StockSEC:0001567619-21-021189:0
281 shares@ US$148.38110.0018% mcap8.0% of flowClass A Common StockSEC:0001567619-21-021189
10,000 shares@ US$5.040.0021% mcap4.4% of flowClass A Common StockSEC:0001567619-21-019299:0
10,000 shares@ US$5.043.0% of flowClass A Common StockSEC:0001567619-21-019299
10,000 shares@ US$5.040.0021% mcap4.4% of flowClass A Common StockSEC:0001567619-21-017949:0
25 of 40 declarations
About McAnear Justin J.
Justin J. McAnear is an executive at 10x Genomics, Inc.
